GLP-1s have rapidly increased in popularity, Due to their seemingly remarkable ability to facilitate weight loss. These findings have led to increased interest in understanding whether GLP-1s might be useful for changing other behaviors, such as as substance use. In this episode, Dr. Joseph Schacht discusses the science behind GLP-1 medications and their potential as treatments for substance use disorders, including recent research, mechanisms, and future directions. Dr. Joseph Schacht is an Associate Professor and Co-Director of the Division of Addiction Science, Prevention, and Treatment in the Department of Psychiatry at the University of Colorado Anschutz. Learn more about his work here.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Samuel Acuff and Noah Emery. Innehållet i podden är skapat av Samuel Acuff and Noah Emery och inte av, eller tillsammans med, Poddtoppen.